Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
NEC Solutions America, a Rancho Cordova, Calif.-based subsidiary of NEC Corp. of Tokyo, has formed a healthcare information technology division called NEC Solutions America Health Care Solutions Division.
InnerWireless Inc. of Richardson, Texas will be showcasing its unified wireless distribution platform that supports a full range of wireless services and applications in hospitals at this year's HIMSS (Healthcare Information and Management Systems Society
Philips Medical Systems this week introduced the HD11 High Definition ultrasound system, the company's third major ultrasound system to be launched in less than 12 months.
Siemens Medical Solutions this week commenced its multi-city educational road show titled "Community Connectivity: Healing Takes Time, Information Shouldn't" in Philadelphia.
The Department of Health and Human Services on Feb. 4 will publish in the Federal Register its proposed rule that will support electronic prescribing for Medicare when the prescription drug benefit takes effect in January 2006.
I don't know how you feel, but I spent more time reading RSNA pre-show, in-show and post-show coverage this year, way beyond what my eye doctor recommends.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
